February 17, 2021 UVA Health Earns National Award for Reducing COVID-19 Infections at Long-Term Care Facilities

UVA Health has received a national health innovation award for its collaborative program to prevent COVID-19 infections at local long-term care facilities and reduce mortality when outbreaks occur.

February 15, 2021 COVID-19 Antibody Testing Suggests Large Majority of Virginians Vulnerable to Virus

Statewide blood testing for COVID-19 has found that only 2% of Virginians had antibodies to the virus as of mid-August.

February 4, 2021 COVID-19: Monoclonal Antibody Drugs Available for High-Risk Patients

UVA Health is offering monoclonal antibody drugs for appropriate COVID-19 patients at highest risk for severe symptoms and hospitalization.

February 3, 2021 Antibody Cocktail Prevents Symptomatic COVID-19 Infections

An antibody cocktail being tested at UVA Health and other sites was able to block 100% of symptomatic COVID-19 infections among people exposed to the virus, early results from the clinical trial suggest.

January 29, 2021 BRHD, UVA Health Partnering on Second Community COVID-19 Vaccination Site

The Virginia Department of Health’s Blue Ridge Health District (BRHD) and UVA Health are partnering to launch a second COVID-19 community vaccination site, which will provide its first vaccinations Sunday. The first group vaccinated at the site Sunday will include Phase 1A frontline workers and Phase 1B essential workers.

January 25, 2021 How UVA Created Artificial Intelligence to Watch Over Patients With COVID-19

A UVA physician’s software that monitors patients to predict clinical problems is helping COVID patients.

January 13, 2021 COVID-19 Trial, Conducted by Mail, Tests Drug to Prevent Hospitalization

At-risk people diagnosed with COVID-19 across the United States and Canada can participate in the testing of a common antidepressant.­­

December 1, 2020 Free COVID-19 Testing Available Dec. 5-6

Priority for the COVID-19 testing will be given to employees of Albemarle County Public Schools, Charlottesville City Schools and the University of Virginia.

November 13, 2020 Antidepressant May Prevent Severe COVID-19, Clinical Trial Finds

The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the School of Medicine suggests.

October 22, 2020 COVID-19: Dexamethasone Discovery Carries Treatment Implications

A new discovery about COVID-19 drug dexamethasone suggests diabetes and other factors may reduce its potentially lifesaving effectiveness.